Central Nervous System (CNS) Stimulant Drugs Market Trends

Statistics for the 2023 & 2024 Central Nervous System (CNS) Stimulant Drugs market trends, created by Mordor Intelligence™ Industry Reports. Central Nervous System (CNS) Stimulant Drugs trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Central Nervous System (CNS) Stimulant Drugs Industry

The Attention-Deficit Hyperactivity Disorder Segment is Expected to Witness Significant Growth Over the Forecast Period

  • The attention-deficit hyperactivity disorder segment is expected to hold a significant market share in the central nervous system (CNS) stimulant drugs market over the forecast period. Factors such as the rising prevalence of attention-deficit hyperactivity disorder amongst children and adolescents and the easy availability of treatment drugs such as CNS stimulants will likely propel the segment growth over the forecast period. 
  • For instance, per the data published by the National Health Insurance Corporation of South Korea in March 2023, the number of individuals diagnosed with attention-deficit hyperactivity (ADHD) has increased in the past few years, and it reached 102,322 in 2021. Further, as per the Centers for Disease Control and Prevention (CDC), in 2021, the approximate number of children detected with attention-deficit/hyperactivity disorder was 6.1 million, with a prevalence rate of 9.4%.
  • Additionally, as per the research study published in the Journal of Education and Health Promotion in 2021, Approximately 5% of kids worldwide suffer from ADHD. According to the same source, 5.29% in Northern America, 12.3% in Southern America, 8.9% in Africa, the Middle East 2.5%, 4.8% in Australia, and Asia account for a 4.2% prevalence of attention-deficit hyperactivity.
  • Therefore, the attention-deficit hyperactivity disorder segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including the rising prevalence of attention-deficit hyperactivity disorder.
Central Nervous System (CNS) Stimulant Drugs Market - Observed and Projected Population of Individuals aged 85 years and Above, In Million, Canada

North America is Expected to Witness Significant Growth Over the Forecast Period

  • North America is expected to experience significant growth in the central nervous system (CNS) stimulant drugs market throughout the forecast period.
  • The development of the central nervous system (CNS) stimulant drugs market is driven by the high healthcare expenditure, high prevalence of central nervous system diseases, expanding geriatric population, and presence of leading market players in the region. For instance, as per the data published by the Centre for ADHD Awareness, Canada (CADDAC) in 2023, ADHD is one of Canada's most common neurodevelopmental disorders, affecting over 1.8 million Canadians. Several clinical trials are ongoing in North America, especially in the United States. More than half of the total neurological disease clinical studies conducted worldwide are in the United States.
  • Also, in March 2021, United States President Biden signed the American Rescue Plan Act 2021. According to the act, a portion of spending is allotted to mental health services, further increasing the government's activities toward neurological diseases. The rising disease burden, healthcare infrastructure, and supportive government initiatives make North America attractive for industries.
  • Furthermore, according to a research study published in the British Medical Journal in 2021, approximately 4.1 million United States adults reported prescriptions for CNS stimulant drugs. The same source reported that the growth rate of the total number of prescriptions dispensed was about 96%, and significant percentage increases occurred in adults aged 25 years and older.
  • Therefore, owing to the factors above, the growth of the studied market is anticipated in the North American region.
Central Nervous System (CNS) Stimulant Drugs Market - Geographic Trend

CNS Stimulant Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)